Michael C Willey
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michael C Willey sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Michael C Willey: 4 sponsored US clinical trials, 2 recruiting.
Michael C Willey sponsors 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hip Dysplasia, with 1 trials.
Upper-quartile sponsor footprint
Michael C Willey sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
NCT06519955
Essential Amino Acid Supplementation for Femoral Fragility Fractures
NCT06050668
Psychosocial Interventions for Young Adults With Hip Pain
NCT04039386
Trauma Screening and Supplementation
NCT03658278
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Michael C Willey pipeline
2 recruiting of 4 indexed (50% open); 1 completed (25%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Hip Dysplasia (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michael C Willey: open-pipeline peers nationwide
Peers matched on 4 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Michael C Willey sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 7 Hills Pharma · 50% recruiting · 2 trials
Related
What to do with this Michael C Willey page
4 registered trials is a research-attention snapshot, not an endorsement of Michael C Willey or any single study.
- 2 of Michael C Willey's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hip Dysplasia is the condition Michael C Willey studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hip Dysplasia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Michael C Willey pipeline card: 4 registered trials from official public datasets.Report a data error.